Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)
Price and Volume
Detailed Quote| Volume | 2,470,210 |
| Open | 118.35 |
| Bid (Size) | 121.81 (100) |
| Ask (Size) | 122.55 (1,000) |
| Prev. Close | 116.82 |
| Today's Range | 117.38 - 122.33 |
| 52wk Range | 61.23 - 122.33 |
| Shares Outstanding | 142,334,900 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
0.7% below 52-week high
121.51
61.2352W Low
122.3352W High
1 Week
0.7% below 1-week high
108.801W Low
122.331W High
Halozyme Therapeutics, Inc. - Common Stock (HALO) traded between $61.23 and $122.33 over the past 52 weeks and last traded at $121.51, 0.7% below its 52-week high. Over the past week it ranged between $108.80 and $122.33.
Past 12 Months
1W
+$11.09
1M
+$15.26
3M
+$43.97
6M
+$54.87
YTD
+$51.20
1Y
+$55.15
HALO was +83.1% over the past year, +82.3% over six months, +72.8% year to date, +10.0% in the last week.
12 Months vs Market
HALO
+83.1%
DIA
+12.6%
SPY
+16.0%
QQQ
+20.9%
IWM
+9.9%
Over the past 12 months HALO returned +83.1% versus DIA (Dow) +12.6%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +20.9% and IWM (Russell 2000) +9.9%.
Volume & Liquidity
1.11× 3-mo avg
Today 2,470,210
3-mo avg 2.2M
1W
2.3M
1M
2.8M
3M
2.2M
6M
2.0M
YTD
2.0M
1Y
2.0M
HALO most recently traded 2,470,210 shares against a 3-month average daily volume of 2.2M.
More News
Read More
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
September 24, 2026
1 Cash-Producing Stock to Target This Week and 2 We Question
September 22, 2026
1 Mid-Cap Stock on Our Watchlist and 2 We Avoid
August 31, 2026
3 Market-Beating Stocks for Long-Term Investors
August 28, 2026
1 Healthcare Stock with Exciting Potential and 2 We Avoid
August 27, 2026
2 Mid-Cap Stocks with Solid Fundamentals and 1 Facing Challenges
August 24, 2026
Halozyme (HALO) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
1 Profitable Stock to Research Further and 2 We Ignore
August 07, 2026
Halozyme Therapeutics Q2 Earnings Call Highlights ↗
August 06, 2026
What To Expect From Halozyme Therapeutics’s (HALO) Q2 Earnings
August 04, 2026
3 Growth Stocks Set to Flourish
August 03, 2026
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
July 24, 2026
1 Value Stock Worth Investigating and 2 Facing Headwinds
July 15, 2026
Frequently Asked Questions
Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 121.51
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 10/15/26 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 17.30B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 17B shares outstanding.